In March 2025, the company introduced new strategies for the direct-to-customer presenting of its Wegovy weight loss drug. The company founded a whole new pharmacy, termed NovoCare, which would cost clients $499 a month for use of the drug, lower than half the cost of the drug through other pharmaceutical distribution networks.[fifty three]Allergic